BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

481 related articles for article (PubMed ID: 28103826)

  • 21. Synchronous endometrioid carcinomas of the uterine corpus and ovary: alterations in the beta-catenin (CTNNB1) pathway are associated with independent primary tumors and favorable prognosis.
    Irving JA; Catasús L; Gallardo A; Bussaglia E; Romero M; Matias-Guiu X; Prat J
    Hum Pathol; 2005 Jun; 36(6):605-19. PubMed ID: 16021566
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular Analysis of Mixed Endometrial Carcinomas Shows Clonality in Most Cases.
    Köbel M; Meng B; Hoang LN; Almadani N; Li X; Soslow RA; Gilks CB; Lee CH
    Am J Surg Pathol; 2016 Feb; 40(2):166-180. PubMed ID: 26492180
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Target-enriched next-generation sequencing reveals differences between primary and secondary ovarian tumors in formalin-fixed, paraffin-embedded tissue.
    Crobach S; Ruano D; van Eijk R; Fleuren GJ; Minderhout I; Snowdowne R; Tops C; van Wezel T; Morreau H
    J Mol Diagn; 2015 Mar; 17(2):193-200. PubMed ID: 25545608
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Synchronous primary cancers of the endometrium and ovary: review of 43 cases].
    Ma SK; Zhang HT; Sun YC; Wu LY
    Zhonghua Zhong Liu Za Zhi; 2008 Sep; 30(9):690-4. PubMed ID: 19173912
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synchronous Endometrial and Ovarian Carcinomas: Evidence of Clonality.
    Anglesio MS; Wang YK; Maassen M; Horlings HM; Bashashati A; Senz J; Mackenzie R; Grewal DS; Li-Chang H; Karnezis AN; Sheffield BS; McConechy MK; Kommoss F; Taran FA; Staebler A; Shah SP; Wallwiener D; Brucker S; Gilks CB; Kommoss S; Huntsman DG
    J Natl Cancer Inst; 2016 Jun; 108(6):djv428. PubMed ID: 26832771
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Discordant Mutations in Paired Primary and Metastatic Endometrial Adenocarcinomas Identified by Semiconductor-Based Sequencing for Rapid Cancer Genotyping.
    Bergstrom CP; Geest K; O'Gara R; Corless CL; Morgan TK
    Reprod Sci; 2016 Nov; 23(11):1575-1579. PubMed ID: 27170661
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Targeted mutation analysis of endometrial clear cell carcinoma.
    Hoang LN; McConechy MK; Meng B; McIntyre JB; Ewanowich C; Gilks CB; Huntsman DG; Köbel M; Lee CH
    Histopathology; 2015 Apr; 66(5):664-74. PubMed ID: 25308272
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Loss of heterozygosity on 10q23.3 and mutation of the tumor suppressor gene PTEN in benign endometrial cyst of the ovary: possible sequence progression from benign endometrial cyst to endometrioid carcinoma and clear cell carcinoma of the ovary.
    Sato N; Tsunoda H; Nishida M; Morishita Y; Takimoto Y; Kubo T; Noguchi M
    Cancer Res; 2000 Dec; 60(24):7052-6. PubMed ID: 11156411
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genetic alterations in endometrial cancer by targeted next-generation sequencing.
    Chang YS; Huang HD; Yeh KT; Chang JG
    Exp Mol Pathol; 2016 Feb; 100(1):8-12. PubMed ID: 26626801
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Morphologic Reproducibility, Genotyping, and Immunohistochemical Profiling Do Not Support a Category of Seromucinous Carcinoma of the Ovary.
    Rambau PF; McIntyre JB; Taylor J; Lee S; Ogilvie T; Sienko A; Morris D; Duggan MA; McCluggage WG; Köbel M
    Am J Surg Pathol; 2017 May; 41(5):685-695. PubMed ID: 28125452
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Disparate genomic characteristics of concurrent endometrial adenocarcinoma and ovarian granulosa cell tumor, revealed by targeted next-generation sequencing.
    Choi YJ; Ho J; Lee A; Hur SY; Park HC; Park JS; Chung YJ; Lee SH
    Pathol Res Pract; 2018 Aug; 214(8):1231-1233. PubMed ID: 29937308
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular evidence for a clonal relationship between synchronous uterine endometrioid carcinoma and ovarian clear cell carcinoma: a new example of "precursor escape"?
    Weng CH; Wu RC; Chen SJ; Chen HC; Tan KT; Lee YS; Huang SS; Yang LY; Wang CJ; Chou HH; Chao AS; Chao A; Lai CH
    J Mol Med (Berl); 2021 Jul; 99(7):959-966. PubMed ID: 33768299
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinicopathologic and survival analyses of synchronous primary endometrial and epithelial ovarian cancers.
    Sozen H; Vatansever D; Iyibozkurt AC; Topuz S; Ozsurmeli M; Salihoglu Y; Guzelbey B; Berkman S
    J Obstet Gynaecol Res; 2015 Nov; 41(11):1813-9. PubMed ID: 26369625
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular biomarkers predicting early development of endometrial carcinoma: A pilot study.
    Lupini L; Scutiero G; Iannone P; Martinello R; Bassi C; Ravaioli N; Soave I; Bonaccorsi G; Lanza G; Gafà R; Loizzi V; Negrini M; Greco P
    Eur J Cancer Care (Engl); 2019 Nov; 28(6):e13137. PubMed ID: 31412428
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synchronous Primary Cancers of the Endometrium and Ovary With the Same Histopathologic Type Versus Endometrial Cancer With Ovarian Metastasis: A Single Institution Review of 72 Cases.
    Bese T; Sal V; Kahramanoglu I; Tokgozoglu N; Demirkiran F; Turan H; Ilvan S; Arvas M
    Int J Gynecol Cancer; 2016 Feb; 26(2):394-406. PubMed ID: 26588233
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Combination of Scoring Criteria and Whole Exome Sequencing Analysis of Synchronous Endometrial and Ovarian Carcinomas.
    Yang L; Zhang L; Huang Q; Liu C; Qi L; Li L; Qu T; Wang Y; Liu S; Meng B; Sun B; Cao W
    Int J Gynecol Cancer; 2018 May; 28(4):704-712. PubMed ID: 29498984
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular Heterogeneity of Endometrioid Ovarian Carcinoma: An Analysis of 166 Cases Using the Endometrial Cancer Subrogate Molecular Classification.
    Leskela S; Romero I; Rosa-Rosa JM; Caniego-Casas T; Cristobal E; Pérez-Mies B; Gutierrez-Pecharroman A; Santón A; Ojeda B; López-Reig R; Palacios-Berraquero ML; Andrada E; Montes S; Pastor F; Gomez MC; López-Guerrero JA; Poveda A; Palacios J
    Am J Surg Pathol; 2020 Jul; 44(7):982-990. PubMed ID: 32384322
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Targeted next-generation sequencing of endometrial cancer and matched circulating tumor DNA: identification of plasma-based, tumor-associated mutations in early stage patients.
    Bolivar AM; Luthra R; Mehrotra M; Chen W; Barkoh BA; Hu P; Zhang W; Broaddus RR
    Mod Pathol; 2019 Mar; 32(3):405-414. PubMed ID: 30315273
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Discordant genetic changes in ovarian and endometrial endometrioid carcinomas: a potential pitfall in molecular diagnosis.
    Chang KH; Albarracin C; Luthra R; Wang L; Zheng W; Malpica A; Deavers MT; Silva EG; Liu J
    Int J Gynecol Cancer; 2006; 16(1):178-82. PubMed ID: 16445630
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synchronous tumours of the female reproductive tract.
    Gilks CB; Kommoss F
    Pathology; 2018 Feb; 50(2):214-221. PubMed ID: 29249564
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.